INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC - BRAINSTORM CELL THERAPEUTICS ownership

BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 94 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC ownership history of BRAINSTORM CELL THERAPEUTICS
ValueSharesWeighting
Q3 2023$1,201
-80.6%
6,000
+100.0%
0.00%
-100.0%
Q2 2023$6,180
-37.6%
3,0000.0%0.00%
-50.0%
Q1 2023$9,900
+101.2%
3,0000.0%0.00%
+100.0%
Q4 2022$4,920
-62.2%
3,0000.0%0.00%
-50.0%
Q3 2022$13,000
+62.5%
3,0000.0%0.00%
+100.0%
Q2 2022$8,000
-20.0%
3,0000.0%0.00%
-50.0%
Q1 2022$10,000
-16.7%
3,0000.0%0.00%0.0%
Q4 2021$12,000
+20.0%
3,0000.0%0.00%0.0%
Q3 2021$10,000
-9.1%
3,0000.0%0.00%0.0%
Q2 2021$11,000
+37.5%
3,000
+50.0%
0.00%0.0%
Q1 2021$8,000
-11.1%
2,0000.0%0.00%0.0%
Q4 2020$9,000
-73.5%
2,0000.0%0.00%
-75.0%
Q3 2020$34,000
+54.5%
2,0000.0%0.01%
+60.0%
Q2 2020$22,000
+144.4%
2,0000.0%0.01%
+150.0%
Q1 2020$9,0000.0%2,0000.0%0.00%0.0%
Q4 2019$9,000
+12.5%
2,0000.0%0.00%0.0%
Q3 2019$8,0000.0%2,0000.0%0.00%0.0%
Q2 2019$8,000
-11.1%
2,0000.0%0.00%0.0%
Q1 2019$9,000
+28.6%
2,0000.0%0.00%0.0%
Q4 2018$7,000
-12.5%
2,0000.0%0.00%0.0%
Q3 2018$8,0000.0%2,0000.0%0.00%0.0%
Q2 2018$8,000
+33.3%
2,0000.0%0.00%
+100.0%
Q1 2018$6,0002,0000.00%
Other shareholders
BRAINSTORM CELL THERAPEUTICS shareholders Q4 2020
NameSharesValueWeighting ↓
Weaver Consulting Group 130,000$437,0000.21%
Ikarian Capital, LLC 304,161$1,022,0000.13%
ABNER HERRMAN & BROCK LLC 265,000$890,0000.12%
S.C. Financial Services, Inc. 15,285$51,0000.06%
JMAC ENTERPRISES LLC 45,430$153,0000.04%
CFO4Life Group, LLC 12,000$40,0000.01%
OSAIC HOLDINGS, INC. 10,839$1,329,0000.00%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 3,000$10,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 29,186$98,0000.00%
RAYMOND JAMES & ASSOCIATES 190,403$640,0000.00%
View complete list of BRAINSTORM CELL THERAPEUTICS shareholders